Duration of medication treatment for opioid-use disorder and risk of overdose among Medicaid enrollees in 11 states: a retrospective cohort study.
Marguerite E BurnsLu TangChung-Chou H ChangJoo Yeon KimKatherine AhrensLindsay AllenPeter CunninghamAdam J GordonMarian P JarlenskiPaul LanierRachel MaukMary Joan McDuffieShamis MohamoudJeffery TalbertKara ZivinJulie M DonohuePublished in: Addiction (Abingdon, England) (2022)
Continuation of medication for opioid use disorder (MOUD) in US Medicaid beneficiaries was associated with a substantial reduction in overdose risk up to 12 months after the first claim for MOUD.